Construction of pBluescript KS+-hPLK
1.25Kb hPLK amplified by RT-PCR with primer P220 and P221
¡õ
Cloned into EcoR V site of pT7Blue by TA cloning
¡õ
wild type hPLK sequence is obtained by PCR based site-directed mutagenesis to
correct the errors in the sequence.
(P239/P240 correct G31.P241/P242 correct T173 to C and G179 to A)
¡õ
two mutant hPLK are subsequently made from the wild type 1.25Kb fragment:
K82D:P235/P236 change bp 245.K82M hPLK has no kinase activity.
AAG for lysine 82 is changed to ATG for methionine.
T210D:P245/P246 change bp A627-C628 into G627-A628.
T210D hPLK has increased kinase activity.
Threonine(ACC)210 is changed to Aspartic acid(GAC)
pT7Blue-hPLK WT, K82M,and T210D cut by BamH I
¡õ
hPLK BamH I fragment is purified by electoelution ¡÷ product 1
W2C clone(partial hPLK sequence between a.a. 258 to stop codon, in pGAD¡EGH)
is cut by BamH I/EcoR I
¡õ
hPLK BamH I/EcoRI fragment is purified by gel electroelution
¡õ
The W2 fragment is cloned into pBluescript KS+ to form pBlueScript KS+-W2C
¡õ
A mutant is made from pBlue KS+-W2C:
¡µKWVD: remove sequence between bp 1237 and bp 1249.
The deletion remove K413-W414-V415-D416. These four amino acids are
part of consensus polo box sequence.¡µKWVD should disrupt the location of hPLK.
pBlue KS+-W2C (WT) and ¡µKWVD
are cut with BamH I, treated with cip ¡÷ product 2
hPLK BamH I fragment is purified by electoelution (product 1)
+
pBlue KS+-W2C (WT) and
¡µKWVD are cut with BamH I, treated with cip (product 2 )
¡õ
complete hPLK sequence in pBluescript KS+
Four construction:WT, K82M, T210D, and ¡µKWVD
to abstract